Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCB1 | P08183 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 2/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | GFER | P55789 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.30 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
| ▸ | ATM | Q13315 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8630325 | 1.00 | ABCB1 (0.41) | ABCB1GAAHPGDTSHRHSD17B10 | |
| SCHEMBL25784631 | 1.00 | ABCB1 (0.41) | ABCB1GAAHPGDTSHRHSD17B10 | |
| SCHEMBL8630324 | 1.00 | ABCB1 (0.41) | ABCB1GAAHPGDTSHRHSD17B10 | |
| SCHEMBL25782621 | 0.82 | ABCB1 (0.43) | ABCB1GAAHPGDTSHRHSD17B10 | |
| SCHEMBL18629597 | 0.82 | ABCB1 (0.43) | ABCB1GAAHPGDTSHRHSD17B10 | |
| SCHEMBL18614588 | 0.82 | ABCB1 (0.43) | ABCB1GAAHPGDTSHRHSD17B10 | |
| SCHEMBL24026905 | 0.82 | ABCB1 (0.43) | ABCB1GAAHPGDTSHRHSD17B10 | |
| SCHEMBL18629599 | 0.82 | ABCB1 (0.43) | ABCB1GAAHPGDTSHRHSD17B10 | |
| SCHEMBL18629603 | 0.82 | ABCB1 (0.40) | ABCB1GAAHPGDTSHRHSD17B10 | |
| SCHEMBL25784645 | 0.78 | ABCB1 (0.35) | ABCB1GAAHPGDTSHRHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210047283-A1 | NOVEL LACTONE COMPOUND AND NOVEL ETHER COMPOUND | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2021-02-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210047283-A1 | NOVEL LACTONE COMPOUND AND NOVEL ETHER COMPOUND | NR0B1, CBR1, DCXR | ABCB1 2441/4885GAA 2954/4885HPGD 2778/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.